Cargando…

Involvement of mesolimbic dopaminergic network in neuropathic pain relief by treadmill exercise: A study for specific neural control with Gi-DREADD in mice

BACKGROUND: Exercise alleviates pain and it is a central component of treatment strategy for chronic pain in clinical setting. However, little is known about mechanism of this exercise-induced hypoalgesia. The mesolimbic dopaminergic network plays a role in positive emotions to rewards including mot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakaizumi, Kenta, Kondo, Takashige, Hamada, Yusuke, Narita, Michiko, Kawabe, Rui, Narita, Hiroki, Watanabe, Moe, Kato, Shigeki, Senba, Emiko, Kobayashi, Kazuto, Kuzumaki, Naoko, Yamanaka, Akihiro, Morisaki, Hiroshi, Narita, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140073/ https://www.ncbi.nlm.nih.gov/pubmed/27909152 http://dx.doi.org/10.1177/1744806916681567

Ejemplares similares

Relief of neuropathic pain by cell-specific manipulation of nucleus accumbens dopamine D1- and D2-receptor-expressing neurons
por: Sato, Daisuke, et al.
Publicado: (2022)

Extracellular N-acetylaspartylglutamate released in the nucleus accumbens modulates the pain sensation: Analysis using a microdialysis/mass spectrometry integrated system
por: Watanabe, Moe, et al.
Publicado: (2018)

Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer
por: Watanabe, Moe, et al.
Publicado: (2018)

Tumor suppression and improvement in immune systems by specific activation of dopamine D1-receptor-expressing neurons in the nucleus accumbens
por: Sato, Daisuke, et al.
Publicado: (2022)

Cancer aggravation due to persistent pain signals with the increased expression of pain-related mediators in sensory neurons of tumor-bearing mice
por: Tanaka, Kenichi, et al.
Publicado: (2023)

Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
por: Suda, Yukari, et al.
Publicado: (2018)

Minimum requirements for the actin-like treadmilling motor system
por: Narita, Akihiro
Publicado: (2011)

Activation of mesolimbic reward system via laterodorsal tegmental nucleus and hypothalamus in exercise-induced hypoalgesia
por: Kami, Katsuya, et al.
Publicado: (2018)

Circadian Rhythms, the Mesolimbic Dopaminergic Circuit, and Drug Addiction
por: McClung, Colleen A.
Publicado: (2007)

Stress-induced alterations of mesocortical and mesolimbic dopaminergic pathways
por: Quessy, F., et al.
Publicado: (2021)

PS13. Role of the hypothalamic µ-opioidergic systems in the anti-tumor immune response
por: Hamada, Yusuke, et al.
Publicado: (2016)

Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Association between Chronic Pain and Alterations in the Mesolimbic Dopaminergic System
por: Yang, Seoyon, et al.
Publicado: (2020)

Level of hM4D(Gi) DREADD Expression Determines Inhibitory and Neurotoxic Effects in the Hippocampus
por: Goossens, Marie-Gabrielle, et al.
Publicado: (2021)

Histone modification of pain-related gene expression in spinal cord neurons under a persistent postsurgical pain-like state by electrocautery
por: Katsuda, Yosuke, et al.
Publicado: (2021)

Impact of Early Consumption of High-Fat Diet on the Mesolimbic Dopaminergic System
por: Naneix, F., et al.
Publicado: (2017)

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
por: Weston, Mikail, et al.
Publicado: (2019)

к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
por: Yamamizu, Kohei, et al.
Publicado: (2013)

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Elucidation of the mechanisms underlying tumor aggravation by the activation of stress-related neurons in the paraventricular nucleus of the hypothalamus
por: Yoshida, Sara, et al.
Publicado: (2023)

Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats
por: Traccis, Francesco, et al.
Publicado: (2021)

Usefulness for the combination of G protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance
por: Mori, Tomohisa, et al.
Publicado: (2017)

On the physiology of jouissance: interpreting the mesolimbic dopaminergic reward functions from a psychoanalytic perspective
por: Bazan, Ariane, et al.
Publicado: (2013)

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
por: McCutcheon, Robert, et al.
Publicado: (2018)

The Use of DREADDs to Deconstruct Behavior
por: Whissell, Paul D., et al.
Publicado: (2016)

Eye-Drops for Activation of DREADDs
por: Keenan, William T., et al.
Publicado: (2017)

Latency to Reward Predicts Social Dominance in Rats: A Causal Role for the Dopaminergic Mesolimbic System
por: Lozano-Montes, Laura, et al.
Publicado: (2019)

Using DREADDs to Isolate Internal Clocks
por: Farrell, Martilias S.
Publicado: (2011)

Chronic DREADD Isn’t As Bad As It Sounds
por: Hyder, Safwan K., et al.
Publicado: (2020)

Side-by-side comparison of the effects of Gq- and Gi-DREADD-mediated astrocyte modulation on intracellular calcium dynamics and synaptic plasticity in the hippocampal CA1
por: Van Den Herrewegen, Yana, et al.
Publicado: (2021)

Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2012)

Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2013)

Is It Possible to Shift from Down to Top Rank? A Focus on the Mesolimbic Dopaminergic System and Cocaine Abuse
por: Amaral, Inês M., et al.
Publicado: (2021)

Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c
por: Narita, Michiko, et al.
Publicado: (2017)

DREADD: A Chemogenetic GPCR Signaling Platform
por: Zhu, Hu, et al.
Publicado: (2014)

From DREADD to Treatment in Temporal Lobe Epilepsy
por: Wong, Jennifer C., et al.
Publicado: (2019)

DREADDs in Epilepsy Research: Network-Based Review
por: Mueller, John-Sebastian, et al.
Publicado: (2022)

The DREADDful Hurdles and Opportunities of the Chronic Chemogenetic Toolbox
por: Claes, Marie, et al.
Publicado: (2022)

Elucidation of the mechanisms of exercise-induced hypoalgesia and pain prolongation due to physical stress and the restriction of movement
por: Tanaka, Kenichi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0een6ose8l3bpkmid4g1dei117